Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 75/100

CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

Tuesday, April 25, 2023 1 min read
Key Takeaway: CytomX Therapeutics, a leader in localized biologics, announced that its CEO, Sean McCarthy, will present at the H.C. Wainwright BioConnect Investor Conference on May 2, 2023. A live webcast of the chat will be available for stakeholders. Additionally, management will hold one-on-one meetings with registered investors. This engagement emphasizes the company's commitment to communicating with investors about its developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is presenting at a prominent investor conference.
  • The event provides an opportunity for one-on-one meetings with investors.
  • The CEO is actively engaging with investors to discuss the company's progress.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ on Tuesday, May 2, 2023 at 11:00 a.m. ET.
A live webcast of the fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations
stephanie.ascher@sternir.com

Frequently Asked Questions

When is CytomX Therapeutics' presentation at the conference?

CytomX Therapeutics will present on May 2, 2023, at 11:00 a.m. ET.

Where can I watch the webcast of the presentation?

The live webcast will be on CytomX’s Events and Presentations page.

Who is presenting at the H.C. Wainwright conference?

Sean McCarthy, D.Phil., CEO and chairman, will be presenting.

Will there be opportunities for one-on-one meetings?

Yes, management will hold one-on-one meetings with registered investors.

What is the trademark associated with CytomX Therapeutics?

Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.

Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics H.C. Wainwright BioConnect Conference investor presentation
Last updated: Apr 25, 2023